Evozym Biologics

About:

Evozym Biologics develops a platform technology that utilizes evolutionary biology to transform gene profiles into novel proteins.

Website: http://evozym.com

Description:

Evozym Biologics, Inc. develops a platform technology that utilizes biology with multi-core computation, algorithms, databases, and biological engineering to transform the evolution of known gene profiles into novel proteins. It produces viable enzyme and protein candidates that perform in specific environmental conditions for industrial applications. The company’s enhanced enzyme technology includes protein and enzyme optimization, and novel compound development for applications in biofuels, biopharmaceuticals, cleaning compounds, and bioremediation. Its computational platform optimizes the structure and function of proteins, as well as enables an output of a portfolio of genomics products for applications in renewable energy, human health, industrial green chemistry, and environmental remediation. The company was founded in 2009 and is based in Lewes, Delaware.

Total Funding Amount:

$600000

Headquarters Location:

Lewes, Delaware, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)evozym.com

Founders:

Adam Marsh, Joseph Grzymski

Number of Employees:

1-10

Last Funding Date:

2011-12-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai